GSK PLC Transfer of Treasury Shares
22 Março 2024 - 1:20PM
RNS Regulatory News
RNS Number : 0288I
GSK PLC
22 March 2024
GSK plc
(the
'Company')
Transfer of Treasury
Shares
On 21 March 2024, the Company
transferred 27,800,000 ordinary shares of 31 1/4 pence each ("Ordinary Shares") that were held by the
Company in treasury ("Treasury
Shares") to JPMorgan Chase Bank, N.A., the depositary of the
Company's American depositary receipts ("ADR") programme, to procure the
issuance and transfer of 13,900,000 ADRs of the Company to the
GlaxoSmithKline (US) Trust (the "Trust"), to be used to satisfy awards
granted under the Company's Deferred Annual Bonus Plan, Performance
Share Plan and Share Value Plan. The
consideration received from the trustee of the Trust of $41.93 per
ADR, representing $20.965 per Ordinary Share, was funded by a
contribution to the Trust from GlaxoSmithKline LLC.
Following the transfer and as at 22
March 2024, the Company's issued share capital consisted of
4,314,051,101 Ordinary
Shares, of which 169,171,155
were held as Treasury Shares.
Therefore, the total number of voting rights in the Company is
4,144,879,946. This figure
may be used by shareholders as the denominator for the calculations
by which they will determine if they are required to notify their
interest in, or a change to their interest in, the Company under
the Financial Conduct Authority's Disclosure Guidance and
Transparency Rules.
Notifications may be sent to
company.secretary@gsk.com.
V A
Whyte
Company Secretary
22 March 2024
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
POSFLFLRVAIFFIS
Gsk (LSE:GSK)
Gráfico Histórico do Ativo
De Ago 2024 até Set 2024
Gsk (LSE:GSK)
Gráfico Histórico do Ativo
De Set 2023 até Set 2024